Market Research Logo

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Global Biochip Markets: Microarrays and Lab-on-a-Chip

The global market for biochip products reached nearly $3.9 billion in 2014. This market is projected to grow from $4.7 billion in 2015 to $18.4 billion in 2020, representing a compound annual growth rate (CAGR) of 31.6% between 2015 and 2020.

This report provides:
An overview of the global market for current and emerging biochip technologies.
Analyses of global market trends, with data from 2014, 2015, and projections of CAGRs through 2020.
Characterizations of biochip markets by type (DNA microarray, protein microarray, emerging microarray, and lab-on-a-chip); by function (gene expression, genotyping, micro-RNA, epigenetic, sequence capture); and by end-user (research-and-development tools, drug discovery and development, diagnostics, sequencing, and applied).
A focused study on the market for biochip-based diagnostics products, a major future segment for biochips.
Discussion of the main commercial biochip technologies and the commercial potential of the key market segments.
Examination of the factors that influence the market, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, and customer needs.
Patent analysis.
Profiles of major players in the industry.


SCOPE AND FORMAT OF REPORT

The study scope includes the major biochip platforms, including DNA and protein microarrays, tissue/cell and glycomics microarrays, LOAC products and NGS. Each platform is analyzed to determine its market status, impact on future market segments, and forecast growth from 2015 through 2020. Technology status and market driving forces are discussed, as well as influencing market factors like industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs and competitive trends.

In addition to the main LOAC, microarray and sequencing industries, BCC Research profiles several specialized biochip industry segments including the following: DNA analyzers, ion channel screening, digital PCR, label-free detection, nanoarray, peptide microarray, antibody microarray, antibody reagents, multiplex protein diagnostics, circulating tumor cell, prenatal screening, point of care CD4 counting and China’s biochips industries.

Applications for biochips-based diagnostics are highlighted in this report — particularly cancer diagnostics — as well as new data about biochip substrate types.

This BCC Research report also analyzes patent data for each biochip type. The industry has grown significantly since the last report, and nearly 300 companies are profiled in our analysis.

The table below highlights the scope of this report and identifies areas that were not analyzed

Not included in the report are bioinformatics products and revenues and service revenues associated with biochips and chemical reagents associated microarrays and LOAC devices.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
CONTRIBUTION OF THE STUDY AND INTENDED AUDIENCE
SCOPE AND FORMAT OF REPORT
TABLE A SCOPE OF REPORT
METHODOLOGY
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
SUMMARY TABLE GLOBAL MARKET FOR BIOCHIP PRODUCTS BY END USE, THROUGH 2020 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET TRENDS FOR BIOCHIP PRODUCTS BY END USE, 2014-2020 ($ MILLIONS)
CHAPTER 3 OVERVIEW
INTRODUCTION
TABLE 1 BIOLOGY DOWNSIZING REVOLUTION
BIOCHIP TYPES
TABLE 2 COMPARISON OF TWO MAJOR BIOCHIP TYPES
TABLE 3 BIOCHIP NOMENCLATURE
MARKET POTENTIAL OF BIOCHIPS
TABLE 4 GLOBAL MARKET FOR BIOCHIP PRODUCTS BY BIOCHIP TYPE, THROUGH 2020 ($ MILLIONS)
DRIVING FORCES FOR GROWTH IN BIOCHIPS MARKETS
TABLE 5 DRIVING FORCES FOR BIOCHIPS KEY MARKET GROWTH
THE BIOCHIP INDUSTRY
TABLE 6 COMPARISON OF BIOCHIPS INDUSTRIES
CHAPTER 4 MICROARRAY TECHNOLOGIES
INTRODUCTION
TABLE 7 THE NANOSCALE WORLD
TABLE 8 TYPES OF MICROARRAY
TABLE 9 COMPARISON OF DNA AND PROTEIN MICROARRAY TECHNOLOGIES
DNA MICROARRAY TECHNOLOGIES
DNA MICROARRAY TYPES
FIGURE 1 MICROARRAY FEATURE DENSITY
FIGURE 2 MICROARRAY RESOLUTION
TABLE 10 MICROARRAY GENOME CONTENT
TABLE 11 DNA MICROARRAY PLATFORM FEATURES
DNA MICROARRAY APPLICATIONS
TABLE 12 APPLICATIONS OF DNA MICROARRAY
TABLE 13 COMPARISON OF GENETIC ANALYSIS TECHNOLOGIES
FIGURE 3 RELATIVE NUMBER OF DISEASE-CAUSING ALLELES AT MAF5
AND MAF1
SNP ANALYSIS
TABLE 14 SNP MEASUREMENT PLATFORMS
EPIGENETIC ANALYSIS
FIGURE 4 UPSTREAM AND DOWNSTREAM STEPS IN EPIGENETIC
ANALYSIS`
CYTOGENETIC ANALYSIS
TABLE 15 COMPARISON OF CHROMOSOMAL CHANGE DETECTION
TECHNOLOGIES
MICRO-RNA ANALYSIS
TABLE 16 WORKFLOW FOR A MICRO-RNA EXPERIMENT
BEAD-BASED ARRAYS
TABLE 17 COMPARISON OF BEAD-BASED ARRAYS AND PLANAR
MICROARRAYS
CATALOG AND CUSTOM DNA MICROARRAYS
PROTEIN MICROARRAY TECHNOLOGIES
INTRODUCTION
FIGURE 5 IMPORTANCE OF PROTEINS
PROTEOMICS WORKFLOW
FIGURE 6 PROTEIN ANALYSIS APPROACHES CONTRASTED
PROTEIN MICROARRAY DESIGN FEATURES
TABLE 18 PROTEIN MICROARRAY PLATFORMS
PROTEIN MICROARRAY APPLICATIONS AS RESEARCH TOOLS
TABLE 19 PROTEIN MICROARRAYS AS RESEARCH TOOLS
PROTEIN MICROARRAY TYPES
TABLE 20 PRODUCT TYPES OF PROTEIN MICROARRAY
PROTEIN MICROARRAY TECHNOLOGY CHALLENGES
TABLE 21 TECHNICAL CHALLENGES OF PROTEIN MICROARRAY
EMERGING MICROARRAY TECHNOLOGIES
TABLE 22 EMERGING MICROARRAY TECHNOLOGIES
GLYCOMICS MICROARRAYS
TISSUE MICROARRAYS
CHAPTER 5 LAB-ON-A-CHIP TECHNOLOGIES
INTRODUCTION
TABLE 23 LOAC PRODUCT LIFE CYCLE STAGE
SUBSTRATE MATERIALS
TABLE 24 BIOCHIPS SUBSTRATE MATERIALS
LOAC TYPES
TABLE 25 TYPES OF LOAC
IN VITRO PROTEOMICS
ELECTROPHORESIS ON A CHIP
STRUCTURAL PROTEOMICS
PCR ON A CHIP
IMMUNOASSAY ON A CHIP
MASS SPECTROMETRY ON CHIP
NEXT-GENERATION SEQUENCING ON CHIP
TABLE 26 WORKFLOW COMPARISON OF SELECTED NEXT-GENERATION
DNA SEQUENCING PLATFORMS
TABLE 27 BIOCHIP CONTENT IN NEXT-GENERATION SEQUENCING
MACHINES
LOAC APPLICATIONS
TABLE 28 SEGMENTS OF LOAC MARKET
TABLE 29 MICROFLUIDIC SYSTEMS ADVANTAGES FOR BIOCHEMICAL
ANALYSIS
ORGAN ON CHIP
LOAC TECHNOLOGY CHALLENGES
TABLE 30 TECHNICAL CHALLENGES OF LOAC TECHNOLOGY
CHAPTER 6 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS
INTRODUCTION
TABLE 31 BIOCHIP KEY LIFE SCIENCES MARKET SEGMENTS
DRUG INDUSTRY CHALLENGES
DRUG DISCOVERY AND DEVELOPMENT PROCESS
FIGURE 7 DRUG DISCOVERY AND DEVELOPMENT TIMESCALE
TABLE 32 BIOCHIP APPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT
DRUG TARGET IDENTIFICATION
DRUG DISCOVERY
Structural Biology
Lead Generation
Lead Optimization
Process R&D
Preclinical and Clinical Trials
NEEDS IN THE DRUG DISCOVERY AND DEVELOPMENT PROCESS
TABLE 33 KEY NEEDS IN DRUG DISCOVERY AND DEVELOPMENT
FIGURE 8 VALIDATION GAP FOR FUTURE DRUG TARGETS
CHAPTER 7 DIAGNOSTICS APPLICATIONS
INTRODUCTION
TABLE 34 DIAGNOSTICS PARADIGM SHIFT
HOW DIAGNOSTICS DIFFER FROM RESEARCH TOOLS
TABLE 35 REQUIREMENTS FOR AN EPIGENETICS BISULFITE DIAGNOSTIC
ASSAY
HOW BIOLOGICAL CONTENT DRIVES THE GROWTH OF DIAGNOSTICS
TABLE 36 BIOMARKERS USED IN BIOCHIP-BASED DIAGNOSTICS
FACTORS IN CLINICAL ACCEPTANCE OF BIOMARKER-BASED TESTS
TABLE 37 RATE OF ADOPTION OF DNA MICROARRAY DIAGNOSTICS TESTS
MOLECULAR DIAGNOSTICS
INTRODUCTION
MARKET CHALLENGES FOR DNA-BASED MDX PLATFORMS
TABLE 38 COMPARISON OF DNA-BASED MDX PLATFORMS
TABLE 39 FACTORS AFFECTING PENETRATION OF NEXT-GENERATION
FORMATS INTO THE MDX MARKET
DIAGNOSTICS MARKET SEGMENTS
TEST SENSITIVITY AND SPECIFICITY
FIGURE 9 SENSITIVITY AND SPECIFICITY
REGULATORY STATUS
BIOCHIPS CANCER APPLICATIONS
CANCER OVERVIEW
TABLE 40 U.S. INCIDENCE FOR SELECTED CANCERS, 2012
BLADDER CANCER
TABLE 41 STATUS OF ADVANCED BLADDER CANCER DIAGNOSTICS
BREAST CANCER
Breast Cancer Screening
Prognosis and Pharmacogenetics Tests
TABLE 42 ESTIMATED NUMBER OF ANNUAL BREAST CANCER
TREATMENT DECISIONS IN THE U.S. BY CANCER
CLASSIFICATION
Breast Cancer MDx Platforms
TABLE 43 BREAST CANCER MDX TECHNOLOGY PLATFORMS
TABLE 44 STATUS OF ADVANCED BREAST CANCER DIAGNOSTICS
CERVICAL CANCER
TABLE 45 STATUS OF ADVANCED HPV DIAGNOSTICS
COLORECTAL CANCER
Conventional Colorectal Cancer Screening Tests
TABLE 46 CURRENT SCREENING AND DIAGNOSTICS TESTS FOR COLORECTAL CANCER
Molecular Colorectal Cancer Diagnostics Tests
TABLE 47 STATUS OF ADVANCED COLORECTAL CANCER
DIAGNOSTICS
CANCER OF UNKNOWN PRIMARY (CUP)
TABLE 48 MDX TECHNOLOGY PLATFORMS FOR DETECTING CUP
KIDNEY CANCER
TABLE 49 STATUS OF ADVANCED KIDNEY CANCER DIAGNOSTICS
LEUKEMIA
TABLE 50 STATUS OF ADVANCED LEUKEMIA DIAGNOSTICS
LIVER CANCER
TABLE 51 STATUS OF LIVER CANCER NEXT-GENERATION DX TESTS
LYMPHOMA
TABLE 52 STATUS OF ADVANCED LYMPHOMA CANCER DIAGNOSTICS
LUNG CANCER
TABLE 53 FIVE-YEAR SURVIVAL RATES FOR NON-SMALL CELL LUNG CANCER (%)
TABLE 54 STATUS OF ADVANCED LUNG CANCER DIAGNOSTICS
MELANOMA
TABLE 55 STATUS OF ADVANCED MELANOMA DIAGNOSTICS
OVARIAN CANCER
TABLE 56 EARLY SCREENING TESTS FOR OVARIAN CANCER
TABLE 57 STATUS OF OVARIAN CANCER NEXT-GENERATION
DIAGNOSTICS TESTS
PANCREATIC CANCER
TABLE 58 STATUS OF ADVANCED PANCREATIC CANCER DIAGNOSTICS
PROSTATE CANCER
TABLE 59 STATUS OF ADVANCED PROSTATE CANCER DIAGNOSTICS
THYROID CANCER
TABLE 60 STATUS OF ADVANCED THYROID CANCER DIAGNOSTICS
SUMMARY OF ADVANCED CANCER DIAGNOSTICS
TABLE 61 NEXT-GENERATION DX TEST SUMMARY BY INDICATION AND TECHNOLOGY
WARFARIN SENSITIVITY
TABLE 62 IMPORTANCE OF CYP GENES IN DRUG METABOLISM (%)
TABLE 63 STATUS OF ADVANCED WARFARIN CYP PHARMACOGENETIC
DIAGNOSTICS
INFECTIOUS DISEASES
TUBERCULOSIS
HOSPITAL-ACQUIRED INFECTIONS
TABLE 64 STATUS OF MRSA AND C. DIFFICILE ADVANCED DIAGNOSTICS
INFLUENZA
TABLE 65 STATUS OF INFLUENZA ADVANCED DIAGNOSTICS
SEXUALLY TRANSMITTED DISEASES
TABLE 66 STATUS OF CT/NG ADVANCED DIAGNOSTICS
OTHER INFECTIOUS DISEASES
NEUROLOGICAL
ALZHEIMER'S DISEASE
TABLE 67 DIAGNOSTICS APPROACHES FOR ALZHEIMER'S DISEASE
TABLE 68 STATUS OF ALZHEIMER'S DISEASE ADVANCED DIAGNOSTICS
TESTS
SCHIZOPHRENIA
CARDIAC DISORDERS
CONGESTIVE HEART FAILURE
TABLE 69 BNP MOLECULAR DIAGNOSTICS TESTS FOR CONGESTIVE
HEART FAILURE
CYSTIC FIBROSIS
TABLE 70 ADVANCED DIAGNOSTICS TESTS FOR CYSTIC FIBROSIS
NONINVASIVE PRENATAL SCREENING
TABLE 71 NEXT-GENERATION SEQUENCING-BASED PRENATAL
DIAGNOSTICS INDUSTRY
IMMUNE DISORDERS
HLA TYPING
TABLE 72 HLA TESTING MARKET
AUTOIMMUNE TESTING
CHAPTER 8 BIOCHIPS INDUSTRY
BIOCHIPS INDUSTRY ACQUISITIONS, 2012 TO 2015
TABLE 73 ACQUISITIONS IN THE BIOCHIPS INDUSTRY, 2012-2015
BIOCHIPS INDUSTRY STRATEGIC ALLIANCES
MICROARRAY INDUSTRY STRATEGIC ALLIANCES
TABLE 74 MICROARRAY INDUSTRY STRATEGIC ALLIANCES, 2012-2013
LOAC INDUSTRY STRATEGIC ALLIANCES
TABLE 75 LOAC/NGS INDUSTRY STRATEGIC ALLIANCES, 2012-2013
LOAC INDUSTRY
LOAC INDUSTRY OVERVIEW
TABLE 76 LOAC COMPETITOR LANDSCAPE
LOAC INSTRUMENT INDUSTRY
TABLE 77 LEADING LOAC INSTRUMENT MANUFACTURERS
LOAC DNA ANALYZER INDUSTRY
TABLE 78 FORENSIC APPLICATIONS FOR LOAC-BASED DNA ANALYZERS
LOAC DIAGNOSTICS INDUSTRY
TABLE 79 LOAC DIAGNOSTICS INDUSTRY
ION CHANNEL SCREENING INDUSTRY
TABLE 80 ION CHANNEL SCREENING INDUSTRY
DIGITAL PCR INDUSTRY
TABLE 81 DIGITAL PCR INDUSTRY
INFLUENTIAL UNIVERSITIES IN THE LOAC INDUSTRY
TABLE 82 LOAC UNIVERSITY SPIN-OFFS
ROLE OF LOAC ACQUISITIONS IN LIFE SCIENCES INDUSTRY
TABLE 83 KEY LOAC ACQUISITIONS BY LEADING LIFE SCIENCE
COMPANIES
NEXT-GENERATION SEQUENCING INSTRUMENT INDUSTRY
TABLE 84 NEXT-GENERATION SEQUENCING INSTRUMENT COMPANIES:
COMMERCIAL PHASE
MICROARRAY INDUSTRY
SUSPENSION BEAD/GEL-BASED MICROARRAY INDUSTRY
TABLE 85 SUSPENSION BEAD/GEL-BASED MICROARRAY INDUSTRY
LABEL-FREE DETECTION INDUSTRY
TABLE 86 LABEL-FREE DETECTION INDUSTRY
NANOARRAY INDUSTRY
TABLE 87 NANOARRAY INDUSTRY
PEPTIDE MICROARRAY INDUSTRY
TABLE 88 KEY PEPTIDE MICROARRAY COMPANIES
ANTIBODY MICROARRAY INDUSTRY
TABLE 89 KEY ANTIBODY MICROARRAY COMPANIES
ANTIBODY REAGENTS INDUSTRY
TABLE 90 ESTIMATED MARKET SHARE FOR KEY ANTIBODY REAGENTS COMPANIES, 2012
BIOCHIPS DIAGNOSTICS INDUSTRY
MULTIPLEX PROTEIN DIAGNOSTICS INDUSTRY
TABLE 91 MULTIPLEX PROTEIN IN VITRO DIAGNOSTICS COMPANIES
CIRCULATING TUMOR CELL INDUSTRY
TABLE 92 CTC BIOCHIPS INDUSTRY
PRENATAL DIAGNOSTICS INDUSTRY
TABLE 93 NORTH AMERICAN TEST COSTS AND PRICES, 2014 ($)
TABLE 94 NEXT-GENERATION SEQUENCING-BASED, NONINVASIVE
PRENATAL DIAGNOSTIC MARKET SHARE BY TEST REVENUE, 2014 (%)
TABLE 95 NONINVASIVE PRENATAL DIAGNOSTICS POTENTIAL FUTURE
COMPETITORS
POC CD4 COUNTING INDUSTRY
TABLE 96 POC CD4 INDUSTRY
AGRICULTURAL INDUSTRY
TABLE 97 BIOCHIPS-BASED COMPANIES IN AGRICULTURAL INDUSTRY
CHINA'S BIOCHIP INDUSTRY
TABLE 98 CHINA BIOCHIP INDUSTRY
CHAPTER 9 BIOCHIPS MARKETS
DRIVING FORCES FOR BIOCHIPS GROWTH
TABLE 99 KEY MARKET GROWTH DRIVING FORCES FOR BIOCHIPS
GLOBAL BIOCHIPS MARKET
TABLE 100 GLOBAL MARKET FOR BIOCHIP PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
TABLE 101 GLOBAL MARKET FOR BIOCHIPS BY END-USE INDUSTRY, THROUGH 2020 ($ MILLIONS)
TABLE 102 PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS
TABLE 103 GLOBAL MARKET FOR BIOCHIPS BY SUBSTRATE MATERIAL, THROUGH 2020 ($ MILLIONS)
DNA MICROARRAY MARKETS
DNA MICROARRAY MARKET BY END-USE INDUSTRY
TABLE 104 GLOBAL MARKET FOR DNA MICROARRAYS BY END USE, THROUGH 2020 ($ MILLIONS)
DNA MICROARRAY MARKET BY ANALYSIS TYPE
TABLE 105 GLOBAL CONTRIBUTION OF DNA MICROARRAYS BY ANALYSIS TYPE, 2015 (%)
FIGURE 10 ENTRIES TO MIRNA DATABASE, 2002-2014 (NO.)
DNA MICROARRAY MARKET BY SUBSTRATE MATERIAL
TABLE 106 GLOBAL MARKET FOR DNA MICROARRAYS BY SUBSTRATE MATERIAL, THROUGH 2020 ($ MILLIONS)
PROTEIN MICROARRAYS MARKETS
INTRODUCTION
TABLE 107 COMPETITIVE PLATFORMS BY MULTIPLEXING DENSITY
PROTEIN MICROARRAYS MARKET BY END-USE INDUSTRY
TABLE 108 GLOBAL MARKET FOR PROTEIN MICROARRAYS BY END USE, THROUGH 2020 ($ MILLIONS)
PROTEIN MICROARRAYS MARKET BY SUBSTRATE MATERIAL
TABLE 109 GLOBAL MARKET FOR PROTEOMIC MICROARRAYS BY SUBSTRATE MATERIAL, THROUGH 2020 ($ MILLIONS)
TABLE 110 COMPETITORS OF COATED MICROARRAY SLIDE MARKET
PRINCIPAL
PROTEOMIC MICROARRAYS MARKET BY ARRAY TYPE
TABLE 111 GLOBAL CONTRIBUTION OF PROTEOMIC ARRAYS BY ARRAY TYPE, 2015 (%)
EMERGING MICROARRAYS MARKETS
EMERGING MICROARRAYS MARKET BY TECHNOLOGY
TABLE 112 GLOBAL CONTRIBUTION OF EMERGING ARRAYS BY ARRAY TYPE, 2015 (%)
EMERGING MICROARRAYS MARKETS BY END-USE INDUSTRY
TABLE 113 GLOBAL MARKET FOR EMERGING ARRAYS BY END USE, THROUGH 2020 ($ MILLIONS)
EMERGING ARRAYS MARKET BY SUBSTRATE TYPE
TABLE 114 GLOBAL MARKET FOR EMERGING ARRAYS BY SUBSTRATE MATERIAL, THROUGH 2020 ($ MILLIONS)
LOAC MARKETS
GENOMICS LOAC MARKET BY END-USE INDUSTRY
TABLE 115 GLOBAL MARKET FOR GENOMICS LAB-ON-A-CHIP BY END-USER INDUSTRY, THROUGH 2020 ($ MILLIONS)
GENOMICS LOAC MARKET BY SUBSTRATE TYPE
TABLE 116 GLOBAL MARKET FOR GENOMICS LOAC BY SUBSTRATE MATERIAL, THROUGH 2020 ($ MILLIONS)
PROTEOMICS LOAC MARKET BY END-USE INDUSTRY
TABLE 117 GLOBAL MARKET FOR PROTEOMIC LOAC BY END-USER INDUSTRY, THROUGH 2020 ($ MILLIONS)
PROTEOMICS LOAC MARKET BY SUBSTRATE TYPE
TABLE 118 GLOBAL MARKET FOR PROTEOMICS LOAC BY SUBSTRATE MATERIAL, THROUGH 2020 ($ MILLIONS)
NGS MARKETS
NGS MARKETS BY END-USER INDUSTRY
TABLE 119 GLOBAL MARKET FOR THE NGS MARKET BY END-USER INDUSTRY, THROUGH 2020 ($ MILLIONS)
NGS MARKET BY SUBSTRATE TYPE
TABLE 120 GLOBAL MARKET FOR NGS BY SUBSTRATE MATERIAL, THROUGH 2020 ($ MILLIONS)
NGS MARKETS BY TEST COMPLEXITY
TABLE 121 GLOBAL CONTRIBUTION OF NGS BY TEST COMPLEXITY, 2015 (%)
BIOCHIPS DIAGNOSTICS MARKETS
INTRODUCTION
DIAGNOSTICS MARKET BY BIOCHIP TYPE
TABLE 122 GLOBAL MARKET FOR DIAGNOSTICS ASSAYS BY BIOCHIP TYPE, THROUGH 2020 ($ MILLIONS)
TABLE 123 ADOPTION RATE FOR DNA MICROARRAYS IN DIAGNOSTICS DIAGNOSTICS MARKET BY INDICATION
TABLE 124 GLOBAL CONTRIBUTION OF DIAGNOSTICS MARKET BY INDICATION, 2015 (%)
DIAGNOSTICS MARKET BY SUBSTRATE MATERIAL
TABLE 125 GLOBAL CONTRIBUTION OF DIAGNOSTICS MARKET BY SUBSTRATE MATERIAL, 2015 (%)
CANCER DIAGNOSTICS MARKET BY BIOCHIP TYPE
TABLE 126 GLOBAL CONTRIBUTION OF CANCER DIAGNOSTICS MARKET BY BIOCHIP TYPE, 2015 (%)
CANCER DIAGNOSTICS MARKET BY INDICATION
TABLE 127 GLOBAL CONTRIBUTION OF CANCER DIAGNOSTICS MARKET BY INDICATION, 2015 (%)
TABLE 128 STATUS OF PROTEOMICS-BASED DIAGNOSTICS FOR CANCER APPLICATIONS, 2015
BIOCHIPS MARKETS BY REGION
REGIONAL MARKET SUMMARY
TABLE 129 GLOBAL MARKET FOR BIOCHIPS BY REGION, THROUGH 2020 ($ MILLIONS)
MICROARRAY MARKET BY REGION
TABLE 130 GLOBAL MARKET FOR MICROARRAY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
LOAC MARKET BY REGION
TABLE 131 GLOBAL MARKET FOR LOAC BY REGION, THROUGH 2020 ($ MILLIONS)
NGS MARKET BY REGION
TABLE 132 GLOBAL MARKET FOR NGS BY REGION, THROUGH 2020 ($ MILLIONS)
CHAPTER 10 BIOCHIPS PATENTS
MICROARRAY PATENTS
TABLE 133 DNA MICROARRAY PATENTS BY REGION, 2002-2012 (NO.)
TABLE 134 MICROARRAY-RELATED PROTEOMICS PATENTS BY REGION, 2002-2012 (NO.)
TABLE 135 MICROARRAY-RELATED PATENTS BY APPLICATION AND TITLE,2013-2015
LOAC PATENTS
TABLE 136 LOAC-RELATED PROTEOMICS PATENTS BY REGION, 2002-2012 (NO.)
TABLE 137 LOAC-RELATED PATENTS BY APPLICATION AND TITLE, 2013-2015
CLINICAL NEXT-GENERATION SEQUENCING PATENTS
CLINICAL NGS PATENTS SUMMARY
TABLE 138 CLINICAL NEXT-GENERATION SEQUENCING PATENTS, 2002-2012 (NO.)
TABLE 139 CLINICAL NGS-RELATED PATENTS BY APPLICATION AND TITLE, 2013-2015
CLINICAL NGS PATENTS BY INDICATION
TABLE 140 CLINICAL NEXT-GENERATION SEQUENCING PATENTS BY INDICATION, 2002-2012 (NO.)
CHAPTER 11 COMPANY PROFILES
3QBD
20/20 GENE SYSTEMS INC.
ABAXIS INC.
ABBOTT LABORATORIES
ABIONIC SA
ABTECH SCIENTIFIC INC.
ABACUS DIAGNOSTICA LTD.
ACCELERATE DIAGNOSTICS INC.
ACEA BIOSCIENCES INC.
ACHIRA LABS PVT. LTD.
ADVANCED LIQUID LOGIC
AFFYMETRIX INC.
AGENDIA BV
TABLE 141 AGENDIA MICROARRAY-BASED DIAGNOSTICS PIPELINE
AGENIX LTD.
AGILENT TECHNOLOGIES INC.
AKONNI BIOSYSTEMS
TABLE 142 AKONNI BIOCHIP GRANTS
ALERE TECHNOLOGIES GMBH
ALLEGRO DIAGNOSTICS CORP.
ALMAC GROUP, LTD.
ANALYTIK JENA AG
AQUAMARIJIN MICRO FILTRATION BV
AQUILA DIAGNOSTIC SYSTEMS INC.
ARRAYIT CORPORATION
ASSURERX HEALTH INC.
ATONOMICS A/S
AUSHON BIOSYSTEMS INC.
AUTOGENOMICS INC.
AVACTA GROUP PLC
AVIANA MOLECULAR TECHNOLOGIES
AXELA INC.
AYOXXA BIOSYSTEMS GMGH
BECKMAN COULTER INC.
BECTON, DICKINSON AND CO.
BIOCARTIS NV
BIOCEPT INC.
BIODOT INC.
BIOFIRE DIAGNOSTICS INC.
BIOFLUIDIX GMBH
BIOFORCE NANOSCIENCES INC.
BIOMERIEUX SA
BIONANOGENOMICS INC.
BIORAD LABORATORIES INC.
BIOSCALE INC.
BIOSURFIT SA
BIOSYSTEMS INTERNATIONAL
BIOTRAY
BLUE4GREEN
BODITECH MED INC.
BOEHRINGER INGELHEIM MICROPARTS GMBH
BOSTON MICROFLUIDICS
CAMBRIDGE BIOMAGNETICS LTD.
CANCER GENETICS INC.
CAPITALBIO CORPORATION
CARIS LIFE SCIENCES
CBC COMPREHENSIVE BIOMARKER CENTER GMBH
CELLANYX DIAGNOSTICS INC.
CELLASIC
CELLECTRICON AB
CELLIX, LTD.
CELLSCAPE CORPORATION
CELLULAR RESEARCH INC.
CELULA INC.
CEPHEID
CLEARBRIDGE BIOMEDICS
COMBIMATRIX MOLECULAR DIAGNOSTICS INC.
COURTAGEN LIFE SCIENCES INC.
CREATIVE MICROSYSTEMS CORPORATION
CUSTOMARRAY INC.
CYBRDI INC.
CYCLOFLUIDIC LTD.
CYNVENIO BIOSYSTEMS INC.
CYTOCENTRICS BIOSCIENCE
CYTOO SA
DEBIOTECH S.A.
DELTADOT LTD.
DEOS LABS
DIAGENIC ASA
DIAGNOSTICS FOR ALL
DIAGNOSWISS S.A.
DIAXONHIT
DNA ELECTRONICS LTD.
DNA LINK INC.
DNAMICROARRAY INC.
DOLOMITE MICROFLUIDICS LTD.
DR. CHIP BIOTECH INC.
DST DIAGNOSTISCHE SYSTEME & TECHNOLOGIEN GMBH
DYCONEX AG
EKSIGENT
ELVEFLOW
ELIM BIOPHARMACEUTICALS INC.
EMULATE INC.
EPIGEM LTD.
EPOCAL INC.
EUROIMMUN AG
FALCON GENOMICS INC.
FLUIDIGM CORPORATION
FLUIDWARE TECHNOLOGIES INC.
FLUIMEDIX APS
FLUXION BIOSCIENCES INC.
FULL MOON BIOSYSTEMS INC.
GEN9 INC.
GENALYTE
GENEFLUIDICS, INC.
GENENEWS
GENEPOC INC.
GENMARK DIAGNOSTICS, INC.
GENOMEDX BIOSCIENCES INC.
GENOMICA SAU
GIGAGEN INC.
GNUBIO INC.
GOOD START GENETICS INC.
GRACE BIO LABS
GRADIENTECH AB
GWC TECHNOLOGIES INC.
GYROS AB
HNU-NANOPOINT
HOLOGIC INC.
ILLUMINA, INC.
IMMUNOVIA AB
INANOVATE INC.
INDX LIFECARE
INNOSIEVE DIAGNOSTICS BV
INSTITUTE OF MICROCHEMICAL TECHNOLOGY CO. LTD.
INTAVIS BIOANALYTICAL INSTRUMENTS AG
INTEL CORPORATION
IQUUM INC.
IRIS BIOTECHNOLOGIES INC.
ISU ABXIS CO. LTD.
JOHNSON & JOHNSON
JPT PEPTIDE TECHNOLOGIES GMBH
KINEXUS BIOINFORMATICS CORPORATION
LAB21 LTD.
LABORATORY CORPORATION OF AMERICA INC.
LC SCIENCES
LEUKODX LTD.
LIFE TECHNOLOGIES INC.
LINEAGEN INC.
LIONIX BV
LUMINEX
MAGARRAY, INC.
MAXWELL SENSORS INC.
MEDIMATE BV
MERCK KGAA
METAMARK GENETICS INC.
MICRO2GEN LTD.
MICROCHIPS INC.
MICRODISH BV
MICRODROP TECHNOLOGIES GMBH
MICROFAB TECHNOLOGIES INC.
MICROFLEXIS GMBH
MICROFLUIDIC CHIPSHOP GMBH
MICROFLUIDIC INNOVATIONS LLC
MICROFLUIDIX INC.
MICROLIQUID
MICROLYTIC
MICRONICS MICROFLUIDICS
MICRONIT MICROFLUIDICS BV
MICROPOINT BIOSCIENCES INC.
MICRUX TECHNOLOGIES SA
MINGYUAN MEDICARE DEVELOPMENT COMPANY LTD.
MOBIDIAG OY/LTD.
MODE DX LTD.
MOLECULAR CYTOMICS INC.
MYCROARRAY INC.
MYCROLAB DIAGNOSTICS PTY LTD.
NANION TECHNOLOGIES GMBH
NANO TERRA INC.
NANOBIOSYM
NANOBIOSYS
NANOCELLECT BIOMEDICAL INC.
NANOENTEK INC.
NANOIVD INC.
NANOMI BV
NANOMIX INC.
NANOSPEED DIAGNOSTICS INC.
NANOSPHERE INC.
NANOSTRING TECHNOLOGIES INC.
NEC CORPORATION
NEOGEN CORPORATION
NEOGENOMICS LABORATORIES
NETBIO INC.
NEXUS DX INC.
NOVARTIS
NUCLEA BIOTECHNOLOGIES INC.
OPKO HEALTH INC.
OPTOTRACK INC.
OSMOTEX AG
OSTENDUM R&D BV
OXFORD GENE TECHNOLOGY
PAMGENE INTERNATIONAL BV
PATHGEN DX PTE LTD.
PATHOGENETIX INC.
PATHOGENICA
PEPPERPRINT GMBH
PEPSCAN PRESTO BV
PERKINELMER
PHALANX BIOTECH GROUP
PHILIPS ELECTRONICS NV
PLEXERA LLC
POSITIVE ID CORPORATION
PROTAGEN AG
PROTEIN BIOTECHNOLOGIES INC.
PROTEUS DIGITAL HEALTH INC.
PROTNETEOMIX SAS
QIAGEN
Q-LINEA AB
QUANTERIX CORPORATION
QUANTISCIENTIFICS LLC
QUANTUM DX
QUEST DIAGNOSTICS
QWANE BIOSCIENCES S.A
RAINDANCE TECHNOLOGIES INC.
RANDOX LABORATORIES LTD.
RAYBIOTECH INC.
RETROGENIX LTD.
RHEONIX
RHEOSENSE INC.
RIDGE DIAGNOSTICS INC.
ROCHE HOLDING AG
ROSETTA GENOMICS INC.
TABLE 143 ROSETTA'S DIAGNOSTICS TESTS
SAMSUNG ELECTRONICS CO. LTD.
SANDSTONE DIAGNOSTICS INC.
SAVYON DIAGNOSTICS LTD.
SCIENION AG
SEEGENE INC.
TABLE 144 SEEGENE BIOCHIPS COLLABORATIONS
SENGENICS INTERNATIONAL PTE LTD
SENSIMED AG
SENSLAB GMBH
SENZAIR B.V.
SFC FLUIDICS LLC
SHANGHAI BIOCHIP CO. LTD.
SHANGHAI HUAGUAN BIOCHIP CO. LTD.
SHARP CORPORATION
SIAMAB THERAPEUTICS INC.
SIGNAL GENETICS LLC
SIGNATURE DIAGNOSTICS AG
SILICON BIOSYSTEMS
SILOAM BIOSCIENCES INC.
SKYLINEDX
SLIPCHIP LLC
SOMALOGIC INC.
SOPHION BIOSCIENCE (BIOLIN SCIENTIFIC)
SPARTAN BIOSCIENCES INC.
SPHERE FLUIDICS LIMITED
SPHERE MEDICAL LTD.
SPINCHIP DIAGNOSTICS AS
SPINOMIX
SQI DIAGNOSTICS, INC.
SURMODICS INC.
SURNETICS
SYSMEX INOSTICS
T2 BIOSYSTEMS
TEARLAB CORPORATION
TECAN GROUP LTD.
THERMO FISHER SCIENTIFIC INC.
THINXXS MICROTECHNOLOGY AG
TIANJIN BIOCHIP CORPORATION
TIRF LABS INC.
TRANSGENOMIC INC.
TRANSLUME INC.
TRINEAN NV
TRINITY BIOTECH PLC
TROVAGENE INC.
US BIOMAX INC.
VERACYTE INC.
VEREDUS LABORATORIES PTE LTD.
WAFERGEN BIOSYSTEMS INC.
WASATCH MICROFLUIDICS
WAVE 80 BIOSCIENCES
WUXI BUOSHENG BIO-ENGINEERING CO. LTD.
XAGENIC INC.
XONA MICROFLUIDICS LLC
YMC CO. LTD.
ZELLKRAFTWERK GMBH
ZYOMYX, INC.
ZYOXEL LTD.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report